Avivagen Inc (CHEXF) 0.0550 $CHEXF Avivagen Announces

Avivagen Inc (CHEXF) 0.0550 $CHEXF

Avivagen Announces Closing of Private Placement Totaling $3.6 million
TheNewswire.ca - Fri Jun 03, 6:01AM CDT
(via Thenewswire.ca)
VIV.VN: 0.070 (unch)

Avivagen Announces CEO Update Important Developments Regarding Use of Antibiotics in Livestock Feeds
TheNewswire.ca - Tue Apr 26, 9:30AM CDT
(via Thenewswire.ca)
VIV.VN: 0.070 (unch)

Avivagen Announces Proposed Chinese Joint Venture to Commercialize OxC-Beta(tm) Livestock
TheNewswire.ca - Thu Apr 14, 6:01AM CDT
(via Thenewswire.ca)
VIV.VN: 0.070 (unch)

Avivagen Announces Voting Results for the Election of its Directors
TheNewswire.ca - Fri Apr 08, 6:00AM CDT
(via Thenewswire.ca)
VIV.VN: 0.070 (unch)

Avivagen Inc. Retains Renmark Financial Communications Inc.
TheNewswire.ca - Tue Mar 29, 6:00AM CDT
(via Thenewswire.ca)
VIV.VN: 0.070 (unch)

Avivagen Announces Results of Swine Trial With COFCO NHRI of the People's Republic of China
TheNewswire.ca - Tue Mar 22, 6:00AM CDT
(via Thenewswire.ca)
VIV.VN: 0.070 (unch)

Avivagen Announces Warrant Extension Exercise Life Extended by 4 Months Approved by the TSX Venture Exchange
TheNewswire.ca - Thu Mar 10, 6:00AM CST
(via Thenewswire.ca)
VIV.VN: 0.070 (unch)

Avivagen Announces New E.U. Broiler Poultry Trial
TheNewswire.ca - Wed Jan 27, 6:00AM CST
(via Thenewswire.ca)
VIV.VN: 0.070 (unch)

Avivagen Approves Advance Notice and Forum Selection By-Law
TheNewswire.ca - Thu Jan 21, 6:00AM CST
(via Thenewswire.ca)
VIV.VN: 0.070 (unch)

Avivagen Announces CEO Update Including OxC-beta(tm) Livestock Trial Results Versus Colistin
TheNewswire.ca - Fri Jan 08, 6:00AM CST
(via Thenewswire.ca)
VIV.VN: 0.070 (unch)

Avivagen Announces Launch of New Website by its Chemaphor Chemical Services Division
TheNewswire.ca - Thu Nov 19, 6:00AM CST
(via Thenewswire.ca)
VIV.VN: 0.070 (unch)

Avivagen Announces Swine Trial Agreement With COFCO NHRI of the People's Republic of China
TheNewswire.ca - Fri Oct 30, 10:22AM CDT
(via Thenewswire.ca)
VIV.VN: 0.070 (unch)

Avivagen Announces Further Swine Trial Agreement With National Institute of Animal Sciences for Vietnam
TheNewswire.ca - Mon Oct 26, 6:00AM CDT
(via Thenewswire.ca)
VIV.VN: 0.070 (unch)

Avivagen Announces First Results of Poultry Trial With Institute of Agro-food Research and Technology of Catalonia
TheNewswire.ca - Thu Oct 22, 6:00AM CDT
(via Thenewswire.ca)
VIV.VN: 0.070 (unch)

Avivagen's Vivamune(tm)Vital Health3 Chews Now Available to U.S. Pet Retailers Unique supplement with OxC-beta(tm) benefits immune system, skin, joint and digestive health for dogs and cats.
TheNewswire.ca - Tue Sep 01, 6:00AM CDT
(via Thenewswire.ca)
VIV.VN: 0.070 (unch)

Avivagen Announces Stock Option Grant
TheNewswire.ca - Thu Aug 20, 6:00AM CDT
(via Thenewswire.ca)
VIV.VN: 0.070 (unch)

Avivagen Announces Poultry Trial Agreement with Institute of Agro-food Research and Technology of Catalonia
TheNewswire.ca - Mon Aug 10, 6:00AM CDT
(via Thenewswire.ca)
VIV.VN: 0.070 (unch)

Avivagen Announces Attendance At The 2015 VetHealth Global Conference
ACCESSWIRE - Tue Jun 09, 6:34AM CDT
OTTAWA, ON / ACCESSWIRE / June 9, 2015 / Avivagen Inc. (TSXV: VIV, PINKSHEETS: CHEXF), a life sciences company that develops and delivers products that support and enhance the health of livestock, pets and people, announces that it is attending the VetHealth Global animal health and nutrition conference on June 9th and 10th, 2015.

Avivagen Announces Conversion of a Liability to Equity and the Grant of Options
ACCESSWIRE - Tue May 19, 6:34AM CDT
OTTAWA, ON / ACCESSWIRE / May 19, 2015 / Avivagen Inc. (TSX VENTURE: VIV, PINKSHEETS: CHEXF), a life sciences company that develops and delivers products that support and enhance the health of livestock, pets and people, announces the conversion of a liability to equity and a grant of options.